Treace Medical Concepts, Inc. logo TMCI - Treace Medical Concepts, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY 0
BUY 2
HOLD 6
SELL 1
STRONG
SELL 0
| PRICE TARGET: $3.00 DETAILS
HIGH: $3.00
LOW: $3.00
MEDIAN: $3.00
CONSENSUS: $3.00
UPSIDE: 7.91%
Annual Quarterly
Metric 2025 2024 2023 2022 2021 2020 2019
Revenue
Revenue 212.7 209.4 187.1 141.8 94.4 57.4 39.4
Cost of Revenue 42.9 41.1 35.2 27.5 16.9 12.5 7.6
Gross Profit 169.8 168.3 151.9 114.3 77.5 44.9 31.8
Operating Expenses
R&D Expenses 20.3 20.6 15.4 13.6 10.2 5.8 5.1
SG&A Expenses 203.6 203.4 187.9 137.6 83.8 38.2 30.2
Other Expenses 0 0 0 (2.0) 0 0 0
Operating Expenses 223.9 224.0 203.4 149.2 94.0 44.0 35.3
Operating Income
Operating Income (54.2) (55.7) (51.4) (34.8) (16.5) 0.9 (3.5)
Interest Expense 5.3 5.3 5.2 4.4 4.1 4.5 0.8
Interest Income 2.8 4.9 6.7 1.3 0.0 0 0.1
Profitability
EBITDA (43.2) (42.1) (39.0) (36.3) (15.8) 2.1 (2.6)
EBIT (53.7) (50.5) (44.4) (38.4) (16.5) 0.9 (3.4)
Income Before Tax (59.0) (55.7) (49.5) (42.8) (20.6) (3.7) (4.3)
Income Tax Expense 0 0 0 0 0 0 0
Net Income (59.0) (55.7) (49.5) (42.8) (20.6) (3.7) (4.3)
Per Share Data
EPS (Basic) -0.93 -0.90 -0.81 -0.77 -0.38 -0.08 -0.10
EPS (Diluted) -0.93 -0.90 -0.81 -0.77 -0.38 -0.08 -0.10
Shares Outstanding 63.3 62.1 60.9 55.3 54.2 51.2 51.2
Metric 2025 2024 2023 2022 2021 2020 2019
Current Assets
Cash & Cash Equivalents 10.7 11.3 13.0 19.5 105.8 18.1 12.1
Short-Term Investments 37.7 64.3 110.2 61.8 0 0 0
Net Receivables 42.2 40.8 38.1 29.2 18.6 14.5 10.4
Inventory 36.0 39.3 29.2 19.3 10.6 7.8 5.6
Other Current Assets 5.5 5.7 7.9 3.6 0 0 0
Total Current Assets 132.1 161.4 198.4 133.4 138.0 41.0 28.6
Non-Current Assets
Property, Plant & Equipment 37.4 34.4 31.6 25.5 2.8 0.8 1.1
Goodwill 12.8 12.8 12.8 0 0 0 0
Intangible Assets 7.1 8.1 9.0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0
Other Non-Current Assets 1.2 0.4 0.1 0.1 0 0 0
Total Non-Current Assets 58.5 55.7 53.5 25.6 2.8 0.8 1.1
Total Assets 190.6 217.1 251.9 159.0 140.8 41.8 29.7
Current Liabilities
Account Payables 6.7 10.5 11.8 8.7 4.1 2.3 0.9
Short-Term Debt 0 0 0 0 0 1.8 0
Deferred Revenue 0 0 0 0 0 0 0
Other Current Liabilities 23.9 2.2 24.2 7.7 0 0.0 0
Total Current Liabilities 30.6 34.9 45.0 30.2 18.2 11.6 7.3
Non-Current Liabilities
Long-Term Debt 14.0 53.3 53.0 52.7 29.4 29.2 19.2
Deferred Tax Liabilities 0 0 0 0 0 0 0
Other Non-Current Liabilities 58.6 0.0 0.0 0 0.2 0.2 0
Total Non-Current Liabilities 72.6 69.3 68.9 68.2 29.5 29.4 19.2
Total Liabilities 103.2 104.2 114.0 98.5 47.7 41.0 26.6
Stockholders' Equity
Common Stock 0.1 0.1 0.1 0.1 0.0 0.0 0.0
Retained Earnings (249.0) (190.0) (134.2) (84.7) (41.9) (21.4) (17.7)
Accumulated Other Comprehensive Income 0.1 0.1 0.2 (0.0) 0 0 0
Total Stockholders' Equity 87.3 112.9 137.9 60.5 93.1 0.8 3.2
Total Liabilities & Equity 190.6 217.1 251.9 159.0 140.8 41.8 29.7
Debt Metrics
Total Debt 14.0 69.7 70.3 68.6 29.4 31.0 19.2
Net Debt 3.3 58.3 57.3 49.1 (76.5) 12.9 7.1
Metric 2025 2024 2023 2022 2021 2020 2019
Operating Activities
Net Income (59.0) (55.7) (49.5) (42.8) (20.6) (3.7) (4.3)
Depreciation & Amortization 10.5 8.4 5.4 2.1 0.7 1.2 0.8
Stock-Based Compensation 33.8 30.6 17.4 8.1 3.4 0.9 0.8
Change in Working Capital (8.6) (25.4) (9.7) (5.8) (1.3) (5.3) (5.3)
Other Non-Cash Items 7.3 5.0 2.0 7.7 0.2 0.2 0.3
Operating Cash Flow (16.0) (37.2) (34.6) (30.6) (17.2) (4.5) (7.7)
Investing Activities
Capital Expenditure (13.5) (11.6) (11.5) (14.8) (2.7) (1.1) (1.2)
Acquisitions 0 0 (20) 61.7 0 0 0
Purchases of Investments (40.6) (71.6) (169.9) (63.4) 0 0 0
Sales/Maturities of Investments 67.3 118.5 120.0 1.7 0 0 0
Other Investing Activities 0 0 0 (61.7) 0 0 0
Investing Cash Flow 13.3 35.4 (81.3) (76.5) (2.7) (1.1) (1.2)
Financing Activities
Net Debt Issuance 2.4 0 0 19.6 (1.8) 11.3 20
Stock Repurchased 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0
Other Financing Activities (0.9) (0.3) (0.0) (1.0) 0 (0.2) (0.3)
Financing Cash Flow 2.1 0.2 109.4 20.8 107.7 11.5 19.7
Cash Position
Net Change in Cash (0.6) (1.6) (6.5) (86.4) 87.8 5.9 10.9
Cash at Beginning 11.3 13.0 19.5 105.8 18.1 12.1 1.3
Cash at End 10.7 11.3 13.0 19.5 105.8 18.1 12.1
Free Cash Flow (29.5) (48.8) (46.0) (45.5) (19.9) (5.6) (8.9)
Key Metrics 2025 2024 2023 2022 2021 2020 2019
Income Statement
Revenue 212.7 209.4 187.1 141.8 94.4 57.4 39.4
Gross Profit 169.8 168.3 151.9 114.3 77.5 44.9 31.8
Operating Income (54.2) (55.7) (51.4) (34.8) (16.5) 0.9 (3.5)
Net Income (59.0) (55.7) (49.5) (42.8) (20.6) (3.7) (4.3)
EPS (Diluted) -0.93 -0.90 -0.81 -0.77 -0.38 -0.08 -0.10
Balance Sheet
Cash & Equivalents 10.7 11.3 13.0 19.5 105.8 18.1 12.1
Total Assets 190.6 217.1 251.9 159.0 140.8 41.8 29.7
Total Debt 14.0 69.7 70.3 68.6 29.4 31.0 19.2
Stockholders' Equity 87.3 112.9 137.9 60.5 93.1 0.8 3.2
Cash Flow
Operating Cash Flow (16.0) (37.2) (34.6) (30.6) (17.2) (4.5) (7.7)
Capital Expenditure (13.5) (11.6) (11.5) (14.8) (2.7) (1.1) (1.2)
Free Cash Flow (29.5) (48.8) (46.0) (45.5) (19.9) (5.6) (8.9)